Bio Green Med Solution, Inc. (BGMS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 700K 1.4M 2.1M FY15: 1.9M FY16: 843K FY17: 0 FY18: 150K FY20: 0 FY21: 0 FY22: 0 FY23: 420K FY24: 43K FY25: 747K FY15 FY16 FY17 FY18 FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Annual

-30M -20M -10M 0 10M 20M 30M FY16: -14.2M FY17: -9.5M FY18: -9.5M FY19: -9.7M FY20: -10.6M FY21: -22.4M FY22: -27.7M FY23: -25.5M FY24: -12M FY25: -8.4M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Net Income Annual

-24M -16M -8M 0 8M 16M 24M FY16: -11.8M FY17: -7.5M FY18: -7.3M FY19: -7.8M FY20: -8.4M FY21: -18.5M FY22: -21.2M FY23: -22.6M FY24: -11.2M FY25: -3M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-24M -16M -8M 0 8M 16M 24M FY16: -10.1M FY17: -7.5M FY18: -6.7M FY19: -9.4M FY20: -7.9M FY21: -18.5M FY22: -20.8M FY23: -16.1M FY24: -8M FY25: -4.8M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-24M -16M -8M 0 8M 16M 24M FY14: -19M FY15: -14.5M FY16: -10.1M FY17: -7.5M FY18: -6.7M FY19: -9.5M FY20: -8M FY21: -18.6M FY22: -20.8M FY23: -16.1M FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 6M 12M 18M FY10: 5.4M FY11: 7.2M FY12: 8.3M FY13: 15.2M FY20: 3.6M FY21: 8.9M FY22: 11.3M FY23: 3.5M FY24: 22.3K FY25: 2.2M FY10 FY11 FY12 FY13 FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-240.00 -160.00 -80.00 0.00 80.00 160.00 240.00 Q2 '14: -0.92 Q3 '14: -0.82 Q4 '14: -0.90 Q1 '15: -0.84 Q2 '15: -1.81 Q3 '15: -2.54 Q4 '15: -3.49 Q1 '16: -4.34 Q2 '16: -4.16 Q3 '16: -4.07 Q4 '16: -3.52 Q1 '17: -2.86 Q2 '17: -2.35 Q3 '17: -2.40 Q4 '17: -1.95 Q1 '18: -1.69 Q2 '18: -1.35 Q3 '18: -0.62 Q4 '18: -0.63 Q1 '19: -3.28 Q2 '19: -5.25 Q3 '19: -7.34 Q4 '19: -9.93 Q1 '20: -8.64 Q2 '20: -7.09 Q3 '20: -5.29 Q4 '20: -4.14 Q1 '21: -3.16 Q2 '21: -3.14 Q3 '21: -3.21 Q4 '21: -2.11 Q1 '22: -2.03 Q2 '22: -1.93 Q3 '22: -1.81 Q4 '22: -27.25 Q4 '24: -230.70 Q1 '25: -228.43 Q2 '25: -57.23 Q3 '25: -14.74 Q4 '25: -5.88 Q2 '15 Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q4 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.